Sixteen crossbred sows (Yorkshire x Duroc) were used to determine the effect of recombinantly derived porcine somatotropin (pST) on lactational performance and the pattern of plasma metabolites and growth rate of nursing pigs. Daily s.c. injections of either pST (8.22 mg.sow-l.d -1) or excipient were administered at 1000 on d 12 through d 29 of lactation. Jugular cannulas were inserted in three sows/treatment and hourly blood samples were collected on d 11 to 13 and d 28 to 29 of lactation to determine the effect of treatment on plasma concentrations of somatotropin, glucose and nonesterified fatty acids in plasma. Milk production and weight of nursing pigs were determined pretreatment (d 9 and 10) and on d 16, 22 and 28. Milk production of sows receiving pST progressively increased above that of control sows and was 22% greater on d 28. Milk composition was not affected by treatment with pST (P > .10), so that the increase in yields of milk fat, lactose and solids paralleled the increases in milk yield. Total milk protein yield tended to be higher in sows receiving pST, but protein yield was greater (P < .10) only on d 28. Pigs suckling sows treated with pST weighed .34 kg more at the end of the lactation period (P < .05). Sows receiving pST consumed less feed (P < .05) during the treatment period, and, as a result, lost more weight (P < .10) and backfat (P < .05) than control sows. Average concentrations of plasma somatotropin were elevated approximately 2.5-fold above baseline levels by exogenous pST. No acute alterations in plasma glucose or nonesterified fatty acids were observed in response to pST treatment, however, sows receiving pST had a chronic elevation of plasma glucose on d 29 of lactation.
Introcluetion
Early weaning (14 to 22 d) is a common practice to enhance sow productivity. However, weaning weight of pigs is a critical consideration because it is integrally related to subsequent performance in the nursery. Although 21-d weights of nursing pigs commonly range from 5.5 to 6.4 kg/pig, artificial rearing studies demonstrate that weights of 7.3 to 8.6 kg are achievable routinely (Jeppeson, 1981) . This is impressive, given that pigs did not have ad libitum access to feed. To our knowledge, the upper limit on weaning weight is unknown, but it appears to be much greater than is achieved presently. Increasing weaning weight improves adaptability and performance in the nursery, resulting in higher survival and faster growth (Boyd et al., 1985) . Methods that enhance milk production could result in a commercially important increase in progeny weaning weight, because a large proportion of the variation in weight is due to milk yield of the sow (Lewis et al., 1978) .
Administration of bovine somatotropin (bST) to lactating dairy cows has substantially increased yield of milk (10 to 40%) and milk components (Johnsson and Hart, 1986; Peel and Bauman, 1987) . It coordinates metabolic processes to partition more nutrients to the mammary gland for milk synthesis . The first study using porcine somatotropin (pST) in sows administered pituitary-derived pST from d 100 of gestation through d 21 of lactation. Milk yield was 16% greater at d 20 of lactation, but feed intake was lower and sows had greater loss of weight and backfat (Spence et al., 1984a) .
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8Lot 13 set at 1.0 IU/mg protein; Miles Laboratory, Elkhart, IN. through 29 of lactation. The specific objectives were 1) to determine the effects of pST on milk production of sows and the weaning weights of the nursing pigs, 2) to characterize the effect of pST on plasma concentrations and patterns of somatotropin (ST), glucose and non-esterified fatty acids (NEFA), and 3) to monitor changes in sow weight and body condition in response to treatment.
Materials and Methods
Sixteen crossbred (Yorkshire x Duroc) multiparous sows (n = 4, 8 and 4 for first, second and third parity, respectively) were allotted randomly within parity to one of two treatment groups (pST or control). Sows were paired and parturition synchronously induced by i.m. injection of 10 mg of prostaglandin F2ct 5 at 0800 on d 111 of gestation. Injections of 40 IU of oxytocin 6 were given i.m. 24 h later to ensure that sows farrowed on d 112 of gestation. Litters were standardized to 10 pigs each within 36 h after farrowing. Sows were housed in farrowing crates and had ad libitum access to a corn-soybean meal diet fortified with vitamins and minerals (Table 1) . Feed offered was recorded at each feeding and total orts were quantified once per week. Nutrient densities (protein, minerals, vitamins) were increased by 30 to 35% over requirements (NRC, 1979) to minimize the chance that nutrient supply would limit milk production response.
Daily injections of either 8.22 mg (11.1 IU, approximately 42.2 kt~/kg BW) of recombinantly derived pST I or excipient were administered subcutaneously at 1000 from d 12 through d 29 of lactation. This preparation was evaluated by American Cyanamid Co. Activity of the pST was 1.35 IU/mg of protein as determined by the rat growth bioassay (Marx et al., 1942 ) using pituitary-derived bST 8 as a reference.
The pST was solubilized in a sterilized saline solution containing .05 M NaHCO3 + Na2CO3 at pH 9.3 to 9.4 (Peel et al., 1981) . Final pST concentration was 1.64 mg/ml and solubilized hormone was stored at 4~ until use (maximum of 5 d). Daily injection volume for both solubilized hormone and excipient (control treatments) was 5 ml.
Milk production for each sow was determined by the weigh-suckle-weigh method (Lewis et al., 1978) modified to encompass a 6-h time period (Speer and Cox, 1984) . Pigs were separated from the sow at 0700 with the first milk yield measurement beginning at 0800. Each nursing and weighing period lasted 15 min, during which time any urine or fecal loss of the pigs was carefully accounted for. The first two nursing intervals were used to acclimate the sow and litter to the procedure and were not included in the calculations. Determinations for the next 4 h were averaged and multiplied by 24 to estimate milk production for that day. Milk yields were determined on d 9, 10, 16, 22 and 28 of lactation. Pretreatment measurements (d 9 and 10) were used in covariate analysis of the milk production data.
Milk samples were acquired on each day that milk production was measured. An i.m. injection of 40 IU of oxytocin was given to stimulate milk ejection and two glands were milked completely. The samples from both glands were mixed and an aliquot was removed. A Bronopol tablet 9 was added as a preservative and samples were frozen at -4"C until analysis. Fat, protein and solids were determined according to standard procedure (AOAC, 1980) . Milk lactose was analyzed by a semiautomatic enzymatic method 10 as described by Eppard et al. (1985) .
Three sows from each treatment group were fitted with indwelling jugular cannulas 4 to 5 d before treatment began. Sows first were sedated with an i.m. injection of xylazine 11 to induce anesthesia, which was maintained with halothane. Silastic medical grade tubing (1.0 mm i.d., 1.8 mm o.d.) was inserted into the external jugular vein through an l 1-gauge needle. The other end of the cannula was fed through a 2.5-cm piece of tubing of large diameter than the cannula. This cuff then was sutured to the sow's neck at a spot near the point where the cannula was exteriorized. Cannula tubing was run along the neck of the sow to a point between the shoulders, and the end was made accessible through a zippered pouch so that blood samples could be collected without disturbing the sow or litter. To maintain patency, cannulas were flushed daily with saline and filled with saline containing heparin (250 IU/ml) and sodium penicillin 12 (50,000 IU/ml). During periods when blood samples were being collected, the cannulas were maintained with 1 M sodium citrate solution.
Blood samples were collected hourly from 0600 on d 11 through 0600 on d 13. These times were selected in order to establish accurate baseline concentrations of metabolites and to monitor any acute responses following the first injection of pST or excipient (d 12, 1000). Hourly samples also were obtained from 0600 on d 29 through 2400 on d 30 to determine the response to the last injection (d 29, 1000) and to characterize the effect of treatment termination on metabolites. Blood for somatotropin analysis was placed into glass vacutainer tubes containing sodium-heparin; blood collected for glucose and NEFA was placed into tubes containing sodium fluoride and potassium oxalate. Plasma fractions were harvested by centrifugation and stored in polypropylene tubes at --4"C until analysis.
Radioimmunoassay of ST in plasma and the iodination of a ST standard was performed according to a modification of the procedure of Marple and Aberle (1972) . Porcine growth hormone (USDA-pGH-B-1) 13 was used for iodination and reference standards. Antisera 14 for pST initially was diluted 1:400 in .05 M EDTA~ (pH 7.4) then further diluted to a working concentration of 1:50,000 in .05 M EDTA-phosphate buffer solution (PBS) (pH 7.4) containing 1:400 normal guinea pig serum. The assay procedure consisted of adding .4 ml of diluent (1% BSA-PBS, pH 7.4), .1 ml of plasma or standard and .2 ml of pST antisera to all tubes on d 1. Tubes were stored at 4"C at all times during the assay. On the 2nd d .1 ml of [125I]pST was added. The [125I]pST was diluted so that each tube contained 16,000 to 20,000 counts per minute, corresponding to .08 to .10 ng of pST/tube (assuming a specific activity of 100 to 150 [tCi/~tg of pST). Twenty-four hours later, .2 ml of the second antibody (anti-guinea pig gamma-globulin; diluted 1:80 with PBS) was added to each tube, bringing the total assay volume to 1 ml. Two days later (the 5th d of the assay), 2.0 ml of PBS (pH 7.4) were added to each tube and tubes were centrifuged for 30 min at 1,600 x g. The supernatant fluid was decanted and the precipitate was counted in a Packard Auto-Gamma Scintillation Spectrometer. Intra-and inter-assay coefficients of variation for the ST analysis were 5.0 and 8.5%, respectively. Plasma NEFA were analyzed by an enzymatic colorimetric method 15 that was modified to accommodate a smaller sample volume . Oleic acid served as standard and intra-and inter-assay coefficients of variation were 1.1 and 2.2%, respectively. Plasma glucose was determined by automated analysis I6. The assay for glucose was based on a modification of the glucose oxidase method (Gochman and Schmitz, 1972) . Coefficients of variation were less than 1%.
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Body weights of the sows were recorded and 10th rib backfat measurements were determined ultrasonically 17 (Barber, 1984) at the beginning and the end of the treatment period. No abnormalities were apparent in sow health as determined by daily rectal temperatures (taken at 0800) and subjective assessment of appearance.
Data for milk production and milk components were analyzed using an analysis of variance procedure appropriate for the splitplot design (SAS, 1982) . Sow was defined as the experimental unit with treatment as main plot and time (subplot) as a repeated measure. The analysis of variance for milk, milk constituents (percentage and yield), pig weights and feed intake included the pretreatment measurements as a covariate in the initial analysis. The covariate did not account for a significant proportion of the sum of squares for any of the variables and subsequently was pooled with the error term.
The effect of exogenous pST on the concentration of ST in the plasma was evaluated by calculating area under the curve. Total area and area above the baseline were analyzed by one-way anaylsis of variance. Area above the baseline was the most appropriate evaluation of pST effects on plasma ST bacause random differences (P < .05) in baseline concentrations (samples acquired from 0600 to 0900) of ST existed between the two treatment groups. Data for plasma glucose and NEFA levels were analyzed using a Student's t-test. Average baseline and postinjection values were tested between treatments within days and between days within a treatment.
Results
The temporal pattern of milk production for both treatment groups is presented in Figure 1 . Pretreatment milk yields (d 9 and d 10 of lactation) were similar for both excipient-and pST-treated sows (8.03 and 7.80 kg/d, respectively). Control sows maximized production by 3 wk and remained relatively constant thereafter, with levels typical of those for relatively high-producing sows (Verstegen et al., 1985) . Treatment with pST increased (P < .10) milk production. Although the treatment x time effect was not significant (P > .10), pST treatment appeared to alter the shape of the lactation curve (Figure 1 ), so that more milk was available early and the supply increased throughout lactation, commensurate with expanding needs of the nursing pigs. By d 28 (d 17 of treatment), milk yield was 22% greater by sows treated with pST (P < .05).
The effect of treatment on milk composition and the yield of milk constituents is summarized in Table 2 . With the exception of lactose, which was higher for pST-treated sows on d 22 (P < .10) and d 28 (P < .01), there were no differences (P > .10) between treatment groups in the percentage of milk components. Thus, the increase observed in total yield of fat, lactose and solids across the treatment period (P < .05) was a function largely of the increased milk yield rather than changed milk composition. Total milk protein yield tended to be greater in pST-treated sows; however, this difference was significant only on d 28 (P < .10).
Growth of the nursing pigs paralleled the increases in milk production of the sows (Table 3) . Pigs from sows receiving laST consistently weighed more than those in the control group, with the difference being significant by d 28 of lactation (P < .05). Approximately 45% of the variation in growth of the pigs was accounted for by the amount of milk and solids produced by the sow. This compared well with a previous estimate (Lewis et al., 1978) and emphasizes the importance of other factors, such as health, environment and genetics, that can influence the growth rate of young pigs.
Both groups of sows consumed approximately the same quantity of feed during the first 2 wk of lactation (Table 4) . Sows receiving the excipient continued to increase their feed intake during the lactation period, coincident with increasing milk yield. In contrast, sows receiving pST failed to increase their feed intake during the 3rd and 4th wk of lactation despite a marked increase in milk production. As a result, sows receiving laST utilized body reserves more extensively, as indicated by greater weight loss and decreased backfat measurements (Table 4) .
Both pST-treated and control sows had a similar concentration (2.7 + .2 ng/ml, average • SE) of ST in plasma on the day prior to the first injection. Administration of pST on both d 12 (Figure 2 ) and 29 (Figure 3 ) resulted in a rise in plasma concentrations of ST being highest over the interval of 2 to 7 h postinjection, followed by a progressive decline until concentrations returned to baseline at about 20 h post-injection.
Area under the curve was used as a criterion for evaluating the increase in average circulating concentrations of ST due to exogenous pST. Area was adjusted for baseline concentration because sows receiving pST had a slightly higher baseline concentration of ST than control sows on d 29 (2.9 vs 2.2 ng/ml). Although temporal patterns were slightly different, injection of pST resulted in a similar increase in total area above the baseline on d 12 and 29, 2.3-and 2.7-fold, respectively. Mean circulating concentrations of ST, on these respective days, were 3.1 and 2.2 ng/ml for control sows and 7.3 and 7.8 ng/ml peripheral blood plasma for sows receiving exogenous pST.
The effect of pST administration on the patterns of plasma glucose and NEFA is presented in Tables 5 and 6 . No acute changes in plasma glucose concentrations were observed in response to pST administration at either the first or last day of the treatment period (Table 5 ). Baseline and postinjection concentrations of plasma glucose on d 12 were similar between treatment groups. However, on d 29 (d 18 of treatment), sows receiving pST exhibited higher plasma glucose concentrations than did control sows throughout the day (P < .05). This elevation in plasma glucose continued the day after treatment ended (d 30) with pST-treated sows averaging 83.7 mg/dl vs 77.1 mg/dl for control sows.
In contrast to an earlier study using pituitary-derived pST (Spence et al., 1984b) , no acute increases in NEFA concentrations were observed in sows following pST treatment (Table 6) .
However, plasma NEFA concentrations were quite variable and tended to increased gradually (nonsignificant, P > .10) throughout the day following the first injection of pST. On the last day of treatment, this effect was not 'observed, and plasma NEFA levels were similar for both treatment groups.
Discussion
This is the first study to demonstrate that administration of recombinantly derived pST to lactating sows increased yield of milk and milk components (Table 2) bCoefticient of variation was calculated using the sow (trtxday) mean square.
*Treatments differ (P < .05). Hart, 1986 and . There are, however, subtle differences between the milk production response observed in cows and our results with sows. First, this magnitude of increase generally has been observed only when cows were treated with exogenous bST during the interval of the lactation cycle when milk yield was declining. The milk yield response observed when cows were treated with bST during the early phase of lactation, a situation analogous to the treatment period in the present study with sows, has been much smaller (Richard et al., 1985) . Second, when bST treatment caused dairy cows to be in a more negative energy balance, milk fat percentage increased (Peel and Bauman, 1987) . Although sows in this study also were in negative energy balance (Table 7) , we observed no alteration in milk fat percent with pST treatment (Table 2) . The treatment period used in this study was chosen to encompass an interval in lactation in which milk yield was presumed to be limiting the growth of the nursing pigs, as demonstrated by Boyd et al. (1985) . For the pSTtreated sows, pigs (10/litter) gained an average of .34 kg/pig more than pigs from control sows over the 17-d treatment period (Table 3) . Assuming an efficiency of .9:1.0 for conversion of milk solids to weight gain of suckling pigs (Braude and Newport, 1977) , the predicted increase in weight gain for pigs from sows receiving pST would be .35 kg per pig. Thus, the increase observed in milk yield with pST treatment affected gain of the litter in the predicted manner.
We observed no acute effects of pST injections on circulating concentrations of glucose and NEFA of sows either on the 1st d or the last d of treatment (Tables 5 and 6 ). However, we did observe that plasma glucose bCoefficient of variation calculated using sow (trtxperiod). CCoefficient of variation calculated using sow(m). *Treatments differ (P <. 10). **Treatments differ (P < .05). aDam represents three sows/treatment. Day 12 of lactation is the rust day and d 29 of lactation the last day of treatment with porcine somatotropin (pST). bcoefficient of variation calculated using sow(time) as an error term.
CBaseline represents the average value of samples acquired for 4 h prior to the injection at 1000. dRepresents averages of hourly samples acquired for a 21-h period immediately following injection at 1000. *Treatments within arow and aday differ (P < .10). **Treatments within a row and a day differ (P < .05).
concentrations were chronically elevated in ST-treated sows at the end of the treatment period. Similar chronic elevations in circulating glucose have been observed during ST treatment of growing pigs (Wray-Cahen et al., 1987) and sheep (Johnsson and Hart, 1985) , but not growing cattle (Eisemann et al., 1986; Sandles and Peel, 1987) or lactating cows . The basis for the elevation in glucose as observed in this study is not known, but the mechanisms associated with glucose homeostasis must have been altered such that blood concentrations of glucose were being maintained chronically at a bCoefficient of variation calculated using sow(time) as an error term. CBaseline represents the average value of samples acquired for 4 h prior to the injection at 1000. dRepresents averages of hourly samples acquired for a 21-h period immediately following injection at 1000 h.
higher level. The absence of acute effects of ST on blood concentrations of NEFA is similar to other recent studies with growing pigs, growing cattle and lactating cows (see reviews by Bauman, 1989) . However, these studies generally have observed a chronic elevation in NEFA when the performance response to ST treatment caused animals to be in a negative energy balance, whereas we observed no change in NEFA even though the ST-treated sows were utilizing body reserves extensively. Our lack of a chronic effect is surprising because in other species tested NEFA are one of the few metabolites in which blood concentrations closely reflect turnover rate and energy balance (Eisemann et al., 1986; Chilliard et al., 1987; Dunshea and Bell, 1987; Bauman et al., 1988) . A striking feature that differed between treatment groups was feed intake. The combination of increased milk yield and a 12% aAveraged from measurements acquired from eight sows/treatment over a 28-d lactation period. bAssumed a maintenance requirement of I 18 KcalAg "75 (Verstegen et al., 1985) . CAssumed 1,256 Kcal MFJkg milk (Agricultural Research Council, 1980 ) and a partial efficiency of 65% for the conversion of metabolizable energy to milk (Verstegen et al., 1985) . lower feed intake required the pST-treated sows to utilize body reserves to a substantially greater extent than control sows, as reflected by a greater weight loss and decrease in backfat thickness (Table 4 ). In addition, the trend for a lower feed intake in pST-treated sows may have limited the lactational response.
Estimated energy balances for control and pST-treated sows are presented in Table 7 . Over the full lactation period, both treatment groups were in negative energy balance, but its extent was about twice as great in the sows receiving pST. This difference would be negated if pST treated sows had consumed an average of 6.15 kg of diet/d. Further, if milk production were increased sufficiently (e.g., +30%, d 7 to 24) to produce a commercially significant increase in weaning weight (1.0 kg assuming .9" 1.0 ratio of milk solids to weaning weight), approximately 6.95 kg feed/d would be required to preclude a greater compromise in body condition.
The basis for the pST effect of feed intake is not clear, but several possibilities exist. One possibility is that pST treatment altered the feedback system involved in the acute or chronic regulation of feed intake. Little is known of the chronic control system, but a number of signals have been identified that have acute effects on the initiation or termination of a meal (NRC, 1987) . One of these is glucose, which raises the possibility that the chronic elevation of glucose in ST-treated sows is being perceived as an indication that energy intake is sufficient to meet nutrient requirements.
Another possibility is that the effect on feed intake may be associated with the purity of the hormone preparation. Somatotropin preparations traditionally have contained varying quantifies of fragments, chemical and conformation artifacts, endotoxins, and(or) other contaminants. There are many examples in the literature where such preparations have given very different responses for specific biological processes than have the more highly purified preparations of somatotropin (see review by Boyd and Bauman, 1989) . In addition, our experience is that pigs, especially lactating pigs, appear to be extremely sensitive to endotoxins. Although the preparation of pST we utilized was highly purified, the possibility that it contained trace levels of contaminants cannot be completely excluded until more sensitive detection systems are developed.
The daily dose of pST employed was approximately 42 ~tg/kg body weight and was similar to that used in our earlier study with lactating sows (Spence et al., 1984a,b) . There has been no dose-response study with lactating sows to determine how dose effects milk production, feed intake and blood variables. In lactating cows, the dose-response curve for milk yield has a pattern of diminishing returns, with the plateau being achieved at a daily dose of ST of approximately 60 }xg,/kg body weight (Bauman et al., 1985a; Eppard et al., 1985) .
The increased production of milk and milk components by sows in this study is another example of the ability of ST to chronically alter metabolism, thereby increasing nutrient utilization of the mammary gland. The mechanism by which ST coordinates metabolism of supportive tissues such as adipose tissue, liver and muscle is unclear, but new information is providing important insights. The action of ST appears to involve a direct action for some tissues, whereas for others the action appears indirect, being mediated by the ST-dependent production of somatomedins such as IGF-I. There is growing evidence that the mammary gland is involved actively in the response to ST with increases in activity per cell, cell number or both (Bauman et al., 1985a) . Although receptors for ST have not been identified in mammary tissue, recent studies have demonstrated that there are receptors for IGF-I on mammary epithelial cells of both sows (Gregor and Burleigh, 1985) and cows (Dehoff et al., 1988) . Thus, ST effects on mammary tissue may be mediated by somatomedins.
In adipose tissue, effects of ST appear to be direct. Recent in vivo studies with growing pigs and cattle and lactating cows demonstrate that the mechanisms involve an altered response of adipose tissue to homeostatic signals that stimulate lipogenesis and lipolysis (see reviews by Etherton and Walton, 1986 and Bauman, 1989) . Thus, ST treatment has effects on both lipid synthesis and lipid mobilization in adipose tissue; the relative magnitude of effects of these processes varies in a predictable manner according to energy status of the animal (Boyd and Bauman, 1989) .
The regulation of nutrient partitioning for lactation and growth has been demonstrated to be the major source of variation in the efficiency of animal production (Bauman et al., 1985b) . Marked differences exist between sows in their ability to consume and partition nutrients in support of lactation. Our results demonstrate that the exogenous administration of pST to lactating sows increases milk production and growth of the suckling pigs. This strategy could become important in practice but will require schemes to ensure adequate feed intake, a variable integrally related both to body condition and to the enhancement of milk yield. Overall, the coordinated changes in the sow to allow more nutrients to be utilized for milk synthesis are consistent with the role of ST as a homeorhetic regulator of nutrient partitioning.
